200 related articles for article (PubMed ID: 17465737)
21. Human induced pluripotent stem cells: a review of the US patent landscape.
Georgieva BP; Love JM
Regen Med; 2010 Jul; 5(4):581-91. PubMed ID: 20632861
[TBL] [Abstract][Full Text] [Related]
22. Patent protection for stem cell procedures under the law of the European Union.
Spranger TM
Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439
[TBL] [Abstract][Full Text] [Related]
23. Patents: patenting of stem cell related inventions in Europe.
Rutz B; Yeats S
Biotechnol J; 2006 Apr; 1(4):384-7. PubMed ID: 16892264
[No Abstract] [Full Text] [Related]
24. European stem cell patents: taking the moral high road?
Bonetta L
Cell; 2008 Feb; 132(4):514-6. PubMed ID: 18295565
[TBL] [Abstract][Full Text] [Related]
25. Differentiating stem cell patents.
Macphie L; Courage N
Pharm Pat Anal; 2012 Sep; 1(4):407-13. PubMed ID: 24236879
[TBL] [Abstract][Full Text] [Related]
26. Herbal drug patenting in India: IP potential.
Sahoo N; Manchikanti P; Dey SH
J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
[TBL] [Abstract][Full Text] [Related]
27. Patenting personalized medicines in the UK, Europe and USA.
Parker S; Hall B
Pharm Pat Anal; 2014 Mar; 3(2):163-9. PubMed ID: 24588593
[TBL] [Abstract][Full Text] [Related]
28. Totipotency/pluripotency and patentability.
Denker HW
Stem Cells; 2008 Jun; 26(6):1656-7. PubMed ID: 18403750
[TBL] [Abstract][Full Text] [Related]
29. The academic advantage: gender disparities in patenting.
Sugimoto CR; Ni C; West JD; Larivière V
PLoS One; 2015; 10(5):e0128000. PubMed ID: 26017626
[TBL] [Abstract][Full Text] [Related]
30. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
31. Stem cell patents--reexamination/litigation--the last 5 years.
Shyntum Y; Kalkreuter E
Tissue Eng Part B Rev; 2009 Mar; 15(1):87-90. PubMed ID: 19260807
[TBL] [Abstract][Full Text] [Related]
32. [Patent protection in modern medical technology].
Bosch M
Biomed Tech (Berl); 2002; 47 Suppl 1 Pt 2():686-7. PubMed ID: 12465274
[TBL] [Abstract][Full Text] [Related]
33. Trends in the human embryonic stem cell patent field.
Karlsson U; Hyllner J; Runeberg K
Recent Pat Nanotechnol; 2007; 1(3):233-7. PubMed ID: 19076035
[TBL] [Abstract][Full Text] [Related]
34. Patenting medical and surgical techniques: an ethical-legal analysis.
Wear SE; Coles WH; Szczygiel AH; McEvoy A; Pegels CC
J Med Philos; 1998 Feb; 23(1):75-97. PubMed ID: 9555635
[TBL] [Abstract][Full Text] [Related]
35. Patenting of human embryonic stem cells in Europe.
Treichel P
Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720
[No Abstract] [Full Text] [Related]
36. Patenting of genome research results.
Stolzenburg F; Weinzierl G; Jaenichen HR
Pharmacogenomics; 2003 Sep; 4(5):633-42. PubMed ID: 12943469
[TBL] [Abstract][Full Text] [Related]
37. Biotechnology patents and ethical aspects.
Terragni F
Cancer Detect Prev; 1993; 17(2):317-21. PubMed ID: 8402719
[TBL] [Abstract][Full Text] [Related]
38. Opponents of stem-cell patent win restrictions.
Abbott A; Schmidt O
Nature; 2002 Aug; 418(6897):470. PubMed ID: 12152046
[No Abstract] [Full Text] [Related]
39. Patenting life forms and preserving human values.
Lisson EL
Hosp Prog; 1981 Jan; 62(1):36-40. PubMed ID: 10289283
[TBL] [Abstract][Full Text] [Related]
40. [Patenting human genetic material: ethical and legal implications].
Bergel SD
Rev Derecho Genoma Hum; 2001; (15):35-64. PubMed ID: 11921892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
